Immunomedics, Inc. is a company in the U.S. stock market and it is a holding in 44 U.S.-traded ETFs. IMMU has around 12.5M shares in the U.S. ETF market. The largest ETF holder of IMMU is the SPDR S&P Biotech ETF (XBI), with approximately 2.92M shares. Investors may also find of interest that the ETF with the largest allocation to IMMU stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 6.14%. On average, U.S. ETFs allocate 0.54% of IMMU to their portfolios.
Additionally, IMMU is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with IMMU as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 27.53%.